Original language | English (US) |
---|---|
Pages (from-to) | 2496-2508 |
Number of pages | 13 |
Journal | Gastroenterology |
Volume | 160 |
Issue number | 7 |
DOIs | |
State | Published - Jun 2021 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Gastroenterology, Vol. 160, No. 7, 06.2021, p. 2496-2508.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease
AU - American Gastroenterological Association Institute Clinical Guidelines Committee
AU - Feuerstein, Joseph D.
AU - Ho, Edith Y.
AU - Shmidt, Eugenia
AU - Singh, Harminder
AU - Falck-Ytter, Yngve
AU - Sultan, Shanaz
AU - Terdiman, Jonathan P.
AU - Sultan, Shahnaz
AU - Cohen, Benjamin L.
AU - Chachu, Karen
AU - Day, Lukejohn
AU - Davitkov, Perica
AU - Lebwohl, Benjamin
AU - Levin, Theodore R.
AU - Patel, Amit
AU - Peery, Anne F.
AU - Shah, Raj
AU - Singh, Siddharth
AU - Spechler, Stuart J.
AU - Staller, Kyle
AU - Thrift, Aaron P.
AU - Weiss, Jennifer M.
N1 - Funding Information: Conflicts of interest These authors disclose the following: Eugenia Shmidt received research support from Celgene and Takeda . Harminder Singh served on the advisory board of Takeda Canada, Pendopharm, Ferring Merck Canada, and Guardant Health Inc., and also received educational funding from Ferring and research funding from Merck Canada . Harminder Singh also served an advisory role to Guardant Health. Jonathan P. Terdiman received research support from Abbvie. The remaining authors disclose no conflicts. All members were required to complete the disclosure statement. These statements are maintained at the American Gastroenterological Association headquarters in Bethesda, Maryland, and pertinent disclosures are published with this report. Funding Information: Conflicts of interest These authors disclose the following: Eugenia Shmidt received research support from Celgene and Takeda. Harminder Singh served on the advisory board of Takeda Canada, Pendopharm, Ferring Merck Canada, and Guardant Health Inc., and also received educational funding from Ferring and research funding from Merck Canada. Harminder Singh also served an advisory role to Guardant Health. Jonathan P. Terdiman received research support from Abbvie. The remaining authors disclose no conflicts. All members were required to complete the disclosure statement. These statements are maintained at the American Gastroenterological Association headquarters in Bethesda, Maryland, and pertinent disclosures are published with this report.
PY - 2021/6
Y1 - 2021/6
UR - http://www.scopus.com/inward/record.url?scp=85106495756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106495756&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2021.04.022
DO - 10.1053/j.gastro.2021.04.022
M3 - Article
C2 - 34051983
AN - SCOPUS:85106495756
SN - 0016-5085
VL - 160
SP - 2496
EP - 2508
JO - Gastroenterology
JF - Gastroenterology
IS - 7
ER -